WDR45B and hepatocellular carcinoma: In order to investigate the potential pathway mechanism of WDR45B in HCC, we analyzed the expression of Akt, mTOR, p-Akt (Ser473), mTOR, and p-mTOR (Ser2481) after the knockdown of WDR45B (Figure 6B).